{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:47:12Z","timestamp":1777956432079,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI132165"],"award-info":[{"award-number":["T32AI132165"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.isci.2025.112850","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:44:00Z","timestamp":1749264240000},"page":"112850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Angela","family":"Florio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Smadbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsay","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiris","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan W.","family":"Feathers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye R.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa F.","family":"McCune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed F.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmohammad","family":"Pezeshki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Grcevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Antonio","family":"De Vitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Schivardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Occhiali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa M.","family":"Larish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Weroha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitesh J.","family":"Borad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos Z.","family":"Anastasiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Vasmatzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112850_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112850_bib2","first-page":"69","article-title":"Type II endometrial cancers: a case series","volume":"7","author":"Lobo","year":"2016","journal-title":"J. Midlife. Health"},{"key":"10.1016\/j.isci.2025.112850_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112850_bib4","doi-asserted-by":"crossref","first-page":"E2373","DOI":"10.1073\/pnas.1520010113","article-title":"The tandem duplicator phenotype as a distinct genomic configuration in cancer","volume":"113","author":"Menghi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112850_bib5","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41467-019-09644-6","article-title":"Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer","volume":"10","author":"Xing","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112850_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccell.2018.07.011","article-title":"Tandem duplications may supply the missing genetic alterations in many triple-negative breast and gynecological cancers","volume":"34","author":"Rao","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.112850_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ccell.2018.06.008","article-title":"The tandem duplicator phenotype is a prevalent genome-wide cancer configuration driven by distinct gene mutations","volume":"34","author":"Menghi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.112850_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2017.11.009","article-title":"SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)","volume":"221","author":"Johnson","year":"2018","journal-title":"Cancer Genet."},{"key":"10.1016\/j.isci.2025.112850_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/gcc.5","article-title":"Copy number variant analysis using genome-wide mate-pair sequencing","volume":"57","author":"Smadbeck","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.isci.2025.112850_bib10","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/annonc\/mdw405","article-title":"Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib","volume":"27","author":"Mansfield","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2025.112850_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/0008-5472.CAN-15-2198","article-title":"Integrated genomic analysis of pancreatic ductal adenocarcinomas reveals genomic rearrangement events as significant drivers of disease","volume":"76","author":"Murphy","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.112850_bib12","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1073\/pnas.1921791117","article-title":"Mechanistic basis for microhomology identification and genome scarring by polymerase theta","volume":"117","author":"Carvajal-Garcia","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112850_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-21-1012","article-title":"Templated insertions are associated specifically with BRCA2 deficiency and overall survival in advanced ovarian cancer","volume":"20","author":"Moore","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.isci.2025.112850_bib14","first-page":"16","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precision Oncol."},{"key":"10.1016\/j.isci.2025.112850_bib15","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112850_bib16","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112850_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ng0504-431","article-title":"The genetic association database","volume":"36","author":"Becker","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.112850_bib18","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/0008-5472.CAN-20-3147","article-title":"The FABRIC cancer portal: a ranked catalogue of gene selection in tumors over the human coding genome","volume":"81","author":"Kelman","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.112850_bib19","doi-asserted-by":"crossref","first-page":"D920","DOI":"10.1093\/nar\/gks1082","article-title":"Atlas of genetics and cytogenetics in oncology and haematology in 2013","volume":"41","author":"Huret","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112850_bib20","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.112850_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mayocp.2019.07.019","article-title":"Integration of comprehensive genomic analysis and functional screening of affected molecular pathways to inform cancer therapy","volume":"95","author":"Vasmatzis","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.isci.2025.112850_bib22","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.2147\/OTT.S206732","article-title":"Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient - a case report","volume":"12","author":"Zhou","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2025.112850_bib23","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/bjc.2014.519","article-title":"Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo","volume":"111","author":"Schwab","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2025.112850_bib24","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/1078-0432.CCR-20-0953","article-title":"Randomized phase II trial of carboplatin-paclitaxel compared with carboplatin-paclitaxel-trastuzumab in advanced (Stage III-IV) or recurrent uterine serous carcinomas that overexpress Her2\/Neu (NCT01367002): updated overall survival analysis","volume":"26","author":"Fader","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.112850_bib25","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.2017.76.5966","article-title":"Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2\/neu","volume":"36","author":"Fader","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112850_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2010.10.015","article-title":"Phase II study of fulvestrant in recurrent\/metastatic endometrial carcinoma: a Gynecologic Oncology Group study","volume":"120","author":"Covens","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.112850_bib28","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/onc.2011.190","article-title":"PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.112850_bib29","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/s41467-021-22708-w","article-title":"PAX8 and MECOM are interaction partners driving ovarian cancer","volume":"12","author":"Bleu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112850_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.13471","article-title":"Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2025.112850_bib31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3892\/or.2017.5485","article-title":"Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt\/\u03b2-catenin signaling pathway in human colorectal adenocarcinoma","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2025.112850_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41416-019-0679-z","article-title":"PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via \u03b2-catenin-dependent regulation of ZEB1","volume":"122","author":"Wu","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2025.112850_bib33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3892\/ijo.2015.3268","article-title":"CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas","volume":"48","author":"Nakayama","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2025.112850_bib34","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.1222577110","article-title":"Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112850_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41065-023-00273-0","article-title":"CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis","volume":"160","author":"Zheng","year":"2023","journal-title":"Hereditas (Lund)"},{"key":"10.1016\/j.isci.2025.112850_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/msb.2013.61","article-title":"Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms","volume":"9","author":"Li","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2025.112850_bib37","first-page":"5519","article-title":"The SNORA21 expression is upregulated and acts as a novel independent indicator in human gastric cancer prognosis","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.isci.2025.112850_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2017.07.009","article-title":"SNORA21 \u2013 an oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer","volume":"22","author":"Yoshida","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2025.112850_bib39","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.molcel.2019.06.020","article-title":"Activation of PARP-1 by snoRNAs controls ribosome biogenesis and cell growth via the RNA helicase DDX21","volume":"75","author":"Kim","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.112850_bib40","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1074\/jbc.M116.758508","article-title":"Long non-coding RNA LINC00672 contributes to p53 protein-mediated gene suppression and promotes endometrial cancer chemosensitivity","volume":"292","author":"Li","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112850_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.518","article-title":"A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma","volume":"5","author":"Tang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2025.112850_bib42","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/onc.2013.89","article-title":"Elevated snoRNA biogenesis is essential in breast cancer","volume":"33","author":"Su","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.112850_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080171","article-title":"Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer","volume":"8","author":"Blenkiron","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112850_bib44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/cells9030541","article-title":"snoRNAs offer novel insight and promising perspectives for lung cancer understanding and management","volume":"9","author":"Mourksi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.112850_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature13311","article-title":"PVT1 dependence in cancer with MYC copy-number increase","volume":"512","author":"Tseng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112850_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrg.2015.17","article-title":"Role of non-coding sequence variants in cancer","volume":"17","author":"Khurana","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.isci.2025.112850_bib47","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/bioinformatics\/btu078","article-title":"BIMA V3: an aligner customized for mate pair library sequencing","volume":"30","author":"Drucker","year":"2014","journal-title":"Bioinformatics"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225011113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225011113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:23:21Z","timestamp":1777947801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225011113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2589004225011113"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112850","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.20.613693","asserted-by":"object"}]},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112850"}}